ClarityInvest logo
CLARITYINVEST

For founders and fundraising operators running an active raise

Your pipeline moved. Your round didn't. Here's why.

A fundraising diagnostic that tests the likely investor-room retell, a possible wrong-room mismatch and the proof needed to move a decision forward.

Downstream of the deck. Upstream of the room.

Diagnostics from €2,500 · 72 hours · Price confirmed before work begins

01

Only a fraction of what you say survives the room. Nobody tells you which fraction — and it's different for every investor.

02

Founders burn real meetings just to stress-test their story. You don't need to anymore.

03

ClarityInvest simulates the conversation before it happens, so you don't go in blind.

04

After the meeting, we compare the likely investor-room read with the feedback and behavior you can observe.

"Strong metrics, but execution risk dominates in a crowded market."

Illustrative retell: if execution risk becomes the room's shorthand, a request for another data point may be testing that risk rather than expressing general enthusiasm. The founder needs to establish which question is actually live.

Three ways momentum leaks.

Each calls for a different next move: change rooms, identify the underlying doubt, or supply decision-relevant proof.

Wrong investor room

The company may be credible, but judged by investors who can't underwrite it now — no amount of follow-up fixes that.

Wrong objection

Founders spend weeks answering surface feedback while the real doubt sits somewhere else entirely.

Wrong proof

Follow-up materials create motion, not progress, when they miss the room's actual decision gap.

Your company enters with nuance. The room keeps a shorter, risk-weighted version.

ClarityInvest makes that compressed version visible before it creates another loop of polite interest, unclear follow-up, valuation pressure, or silence.

Investor-room signal compression
The company enters the meeting with nuance. What survives afterward is shorter, sharper, and more risk-weighted.

We predict the objection before the room says it out loud — then check.

Every diagnostic is produced blind — before we see any feedback from your real investor conversations. That's how we know the read is accurate, not just plausible-sounding.

3–4 of 5

Objections and kill signals we flag are typically confirmed independently by the room within weeks.

Blind

Every diagnostic is produced before we see your real investor feedback — then checked against it.

€0

We don't publish a manufactured close-rate or time-saved percentage. See the example for exactly how we track accuracy.

The same decision-pressure problem, from the other side of the table.

ClarityInvest Secondaries helps investment teams decide which private-company secondary opportunities deserve another underwriting cycle.

Philippe Sayegh

Founder-side reality, sharpened by investor-room pattern recognition.

ClarityInvest is led by Philippe Sayegh, a founder and advisor who has raised, exited, and sat in investor rooms. The work is sharpened by a small circle of operators and advisors with fundraising, exit, and institutional investor-room experience.

Read the full story →

Running several raises at once? The same leaks compound.

For fractional CFOs, fundraising leads and accelerators, recurring room mismatch and objection patterns become a portfolio-wide tax.

Find the leak before it costs you another meeting.

If a second meeting led to silence, read how to clarify the next decision. If requests keep multiplying, test what the additional information must prove.

The intake checks whether your issue is room fit, investor retell, proof gap, avoidable fundraising drag, or something ClarityInvest should not touch.

No commitment · Free routing call · Diagnostics from €2,500